Table 1.
Demographic characteristics of cohort at study midpoint 1st July 2008, n = 12,373
| Age in yearsa | 68.2 (59.2-75.9) |
| Sex (M) (%) | 6636 (54) |
| Metformin Use (%) | 5975 (48) |
| Diabetes Duration in yearsa | 5.48 (2.50-9.91) |
| Number of diabetes drug classes prescribed (%) | |
| 0 | 4187 (33.8) |
| 1 | 4517 (36.5) |
| 2 | 2943 (23.8) |
| 3 | 671 (5.4) |
| 4 | 53 (0.4) |
| 5 | 2 (0.02) |
| eGFR category (%) | |
| >60 | 8926 (72.1) |
| 30-59 | 2574 (20.8) |
| <29 ml/min/1.732 | 180 (1.5) |
| Missing | 693 (5.6) |
| HbA1c % | 7.0 (6.3 – 7.9) |
| (mmol/mol) | 53 (45- 63) |
| ACE inhibitor or ARB Use (%) | 5074 (41%) |
| NSAID or Cox-2 inhibitor use (%) | 1160 (9.4%) |
aMedian & IQR